Cargando…

Flecainide in Ventricular Arrhythmias: From Old Myths to New Perspectives

Flecainide is an IC antiarrhythmic drug (AAD) that received in 1984 Food and Drug Administration approval for the treatment of sustained ventricular tachycardia (VT) and subsequently for rhythm control of atrial fibrillation (AF). Currently, flecainide is mainly employed for sinus rhythm maintenance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lavalle, Carlo, Trivigno, Sara, Vetta, Giampaolo, Magnocavallo, Michele, Mariani, Marco Valerio, Santini, Luca, Forleo, Giovanni Battista, Grimaldi, Massimo, Badagliacca, Roberto, Lanata, Luigi, Ricci, Renato Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397118/ https://www.ncbi.nlm.nih.gov/pubmed/34441994 http://dx.doi.org/10.3390/jcm10163696

Ejemplares similares

Flecainide How and When: A Practical Guide in Supraventricular Arrhythmias
por: Lavalle, Carlo, et al.
Publicado: (2021)

Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance Network
por: Lavalle, Carlo, et al.
Publicado: (2022)

The scar: the wind in the perfect storm—insights into the mysterious living tissue originating ventricular arrhythmias
por: Pandozi, C., et al.
Publicado: (2022)

Catheter ablation for papillary muscle arrhythmias: A systematic review
por: Mariani, Marco Valerio, et al.
Publicado: (2022)

Catheter Ablation of Life-Threatening Ventricular Arrhythmias in Athletes
por: Tarantino, Nicola, et al.
Publicado: (2021)

Electrocardiographic Criteria for Differentiating Left from Right Idiopathic Outflow Tract Ventricular Arrhythmias
por: Mariani, Marco V, et al.
Publicado: (2021)

Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis
por: Mariani, Marco Valerio, et al.
Publicado: (2020)

The Antiarrhythmic Mechanisms of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia
por: Li, Yukun, et al.
Publicado: (2022)

Insights on the mechanism of flecainide in catecholaminergic polymorphic ventricular tachycardia
por: Davidson, Ross, et al.
Publicado: (2023)

Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing)
por: Boriani, Giuseppe, et al.
Publicado: (2020)

Five waves of COVID-19 pandemic in Italy: results of a national survey evaluating the impact on activities related to arrhythmias, pacing, and electrophysiology promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing)
por: Boriani, Giuseppe, et al.
Publicado: (2022)

Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients
por: Magnocavallo, Michele, et al.
Publicado: (2022)

HeartLogic™: real-world data—efficiency, resource consumption, and workflow optimization
por: Mariani, Marco Valerio, et al.
Publicado: (2023)

New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events
por: Lavalle, Carlo, et al.
Publicado: (2023)

Questioning flecainide's mechanism of action in the treatment of catecholaminergic polymorphic ventricular tachycardia
por: Williams, Alan J., et al.
Publicado: (2016)

Idiopathic premature ventricular complexes treatment: Comparison of flecainide, propafenone, and sotalol
por: Kojić, Dejan, et al.
Publicado: (2023)

Flecainide in clinical practice
por: Basza, Mikołaj, et al.
Publicado: (2022)

A Case of Acute Ventricular Capture Threshold Rise Associated with Flecainide Acetate
por: Kang, Tae Soo, et al.
Publicado: (2006)

An electrocardiographic series of flecainide toxicity
por: Smith, Alexandra, et al.
Publicado: (2018)

The Unpaceable Heart: Flecainide Toxicity?
por: Haffajee, Charles, et al.
Publicado: (2020)

Impact of COVID-19 Pandemic on Cardiac Electronic Device Management and Role of Remote Monitoring
por: Magnocavallo, Michele, et al.
Publicado: (2022)

Brugada ECG Pattern Unmasked by IV Flecainide in an Individual with Idiopathic Fascicular Ventricular Tachycardia
por: Gavin, Andrew R, et al.
Publicado: (2013)

Efficacy of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia Is Mutation-Independent but Reduced by Calcium Overload
por: Hwang, Hyun Seok, et al.
Publicado: (2019)

Flecainide exerts paradoxical effects on sodium currents and atrial arrhythmia in murine RyR2-P2328S hearts
por: Salvage, S C, et al.
Publicado: (2015)

The Role of MicroRNA in the Myocarditis: a Small Actor for a Great Role
por: Chimenti, Cristina, et al.
Publicado: (2023)

Protection against Ischemic Heart Disease: A Joint Role for eNOS and the K(ATP) Channel
por: Severino, Paolo, et al.
Publicado: (2023)

Stereotactic Arrhythmia Radioablation Treatment of Ventricular Tachycardia: Current Technology and Evolving Indications
por: Guarracini, Fabrizio, et al.
Publicado: (2023)

A Case of Flecainide-Induced Hyponatremia
por: Ntemka, Alexandra, et al.
Publicado: (2023)

A mobile app for improving the compliance with remote management of patients with cardiac implantable devices: a multicenter evaluation in clinical practice
por: Lavalle, Carlo, et al.
Publicado: (2022)

Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients
por: Pölönen, R. P., et al.
Publicado: (2018)

Hypersensitivity reactions to food and drug additives: problem or myth?
por: Laura, Andreozzi, et al.
Publicado: (2019)

Successful treatment of arrhythmia with β‐blocker and flecainide combination in pregnant patients with Andersen–Tawil syndrome: A case report and literature review
por: Rujirachun, Pongprueth, et al.
Publicado: (2020)

Safety and efficacy of flecainide for patients with catecholaminergic polymorphic ventricular tachycardia: A systematic review and meta-analysis
por: Wang, Guangqiang, et al.
Publicado: (2019)

Ventricular fibrillation in lone atrial fibrillation as clinical manifestation of latent Brugada syndrome: Usefulness of flecainide testing
por: Pappone, Carlo, et al.
Publicado: (2015)

Flecainide intoxication in pediatric patients with supraventricular tachycardia
por: Vaquer, Guiem, et al.
Publicado: (2020)

Flecainide-Induced Left Bundle Branch Block
por: Nuthulaganti, Swetha R, et al.
Publicado: (2022)

Flecainide-induced pneumonitis: a case report
por: Moureau, Gauthier, et al.
Publicado: (2022)

Common Molecular Determinants of Flecainide and Lidocaine Block of Heart Na(+) Channels: Evidence from Experiments with Neutral and Quaternary Flecainide Analogues
por: Liu, Huajun, et al.
Publicado: (2003)

Cardiopulmonary Support During Catheter Ablation of Ventricular Arrhythmias With Hemodynamic Instability: The Role of Inducibility
por: Grimaldi, Massimo, et al.
Publicado: (2021)

Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
por: Caputo, Annalisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ecfubf9llp8nblskuvcs0v13rm